9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025

Cited by (728)

Items 701–728 of 728

1. Capítulo 20. Tratamiento de enfermedades específicas | Chapter 20. Treating specific disease states
   Robert M. Mueller, Jeri Sias · 2026 · The American Pharmacists Association eBooks
2. Targeted Regulation of Pancreatic Islet Function by Natural Products Against Type 2 Diabetes Mellitus: Advances and Prospects
   Guanrong Qiao, Oluwaniyi Isaiah Adejobi, Xuefang Li, Yaqin Yang, Xudong He, Li Li, Yue Zhou, Jiawei Li, Hao Li, Fan Zhang et al. · 2026 · Biomolecules
3. Analysis of Antidiabetic Prescriptions for Patients with Type 2 Diabetes at the National Teaching Hospital in Cotonou, Benin
   Comlan Jules Gninkoun, Djeneba Sylla Sow, Joseph Fanou · 2026 · Open Journal of Endocrine and Metabolic Diseases
4. Antioxidants as a Link Between Diabetes and Potential Plant-Based Therapies
   Alina Kuryłowicz, Leszek Dobrowolski, Monika Słupecka‐Ziemilska, Zuzanna Kościów, Marta Kuczeriszka · 2026 · Antioxidants
5. Impact of two consecutive rounds of National Volume-Based Procurement (NVBP) for insulin on utilisation and structure: a quasi-experimental study using interrupted time series analysis in Hubei, China
   Jinyi Tao, Shihong Li, Jiajie Tan · 2026 · BMJ Open
6. Associations of mortality and sepsis after GLP-1 receptor agonist initiation versus SGLT2 inhibitor or metformin initiation in people with HIV, overweight or obesity, and type 2 diabetes: A target trial emulation
   Yu‐Nan Huang, Pei-Yun Li, Kai-Wen Liu, Pin‐Hung Li, Shao-Chia Chen, Jo‐Ching Chen, Gideon Meyerowitz‐Katz, Jing-Yang Huang, Pen‐Hua Su · 2026 · Therapeutic Advances in Endocrinology and Metabolism
7. Beyond Weight Loss and Glycemic Control: Molecular Mechanisms and Hypothesis-Generating Therapeutic Potential of Incretin-Based Therapies Against Peritoneal Fibrosis in Peritoneal Dialysis
   Yi‐Chen Li, Jui-Ting Hsu, Chung-Ming Fu, Ting-Chun Liu, Yueh‐Ting Lee, Po-Jung Wu, Lung‐Chih Li, Terry Ting‐Yu Chiou, Chien-Hua Chiu, Wei‐Hung Kuo et al. · 2026 · Pharmaceuticals
8. Circadian Misalignment and Chrononutrition in Type 2 Diabetes: Mechanistic Insights and Translational Gaps
   Ismail Celil Haskologlu, Zeynep Güneş Özünal · 2026 · International Journal of Molecular Sciences
9. Comparative Effectiveness of Once-Weekly Semaglutide Versus Sulfonylureas, DPP4 Inhibitors, and Thiazolidinediones in Patients with Type 2 Diabetes and Chronic Kidney Disease
   James J. Amamoo, Yan Wang, Hongjiao Liu, Manasvi Sundar, Yan Song, Lin Xie, SHERIF J. MEHANNA, Josh M. Noone, Caroline Swift, Matthew R. Weir · 2026 · Advances in Therapy
10. IcoSema in Weight Management and Glycaemic Control: A Systematic Review and Meta-Analysis
    Mahmoud Ismail Nouh, Hani Raka Karrar, Hala Albuti, Rehab Salah Aldin Alhendi, Sara A Alharbi, Sarah M Alfakih, Fatehi Y Thabit, Mohammed Ameer Essaa Abdulrahman, Abdelaziz M Aman, Ghadeer M Murshid et al. · 2026 · Cureus
11. Resetting the glucose sensor: dorzagliatin and the evolution of glucokinase activation in diabetes therapy
    Mingxing Chang, Shen Peipu, Guifang Shen · 2026 · BMJ Open Diabetes Research & Care
12. NT-proBNP–echocardiographic discordance in type 2 diabetes: links with adiposity and left atrioventricular coupling
    Yueyao Zhao, Lina Zhao, Zhourui Liu, Yao Zhang, Jiajue Tan, Nan Chen, Sha Li, Bei Zhang · 2026 · Frontiers in Endocrinology
13. Insulin Degludec in the Management of Hyperglycemia in Pregnancy: Real-World Evidence on Glycemic Control and Outcomes
    Rutul Gokalani, Piyush Desai, Chawla Manoj, DIPAK B. CHUDASAMA, Subhajyoti Ghosh, Abhishek Srivastava, Vrunda Bhatt, Deepak Kumar Das, Aswin Mukundan, Munjal Pandya et al. · 2026 · Journal of Diabetology
14. Bioequivalence Assessment of Sitagliptin/Metformin Extended-Release Fixed-Dose Combinations in Healthy Mexican Subjects Under Fasting and Fed Conditions
    Omar Emmanuel Hernández Piña, Porfirio de la Cruz Cruz, Erika Gabriela Guido Ávila · 2026 · Pharmaceuticals
15. Comparison of the Efficacy of Once Weekly Dose of Trelagliptin Versus Once Daily Dose of Vildagliptin on the Levels of HbA1c in Type-2 Diabetes Patients
    Bilal Hussain, Ehsan Ullah, Farah Sadiq · 2026 · Pakistan Journal of Health Sciences
16. GLP-1 receptor agonists—a potential therapy for chronic kidney disease?
    Jan Boeckhaus, John Andrew Sayer, Holly R. Mabillard · 2026 · Clinical Science
17. Global Landscape and Thematic Evolution of Selective GLP ‐1 Receptor Agonists and GLP ‐1–Based Multi‐Receptor Agonists in Type 2 Diabetes Mellitus: A Bibliometric Analysis
    Yanbing Wang, Zhanru Liu, Shifeng Wang, Cuiyan Lv, Hesham Rushdey El-Seedi, Shaden A M Khalifa, Haiyan Wang · 2026 · Endocrinology Diabetes & Metabolism
18. Dyslipidemia in cardio-reno-metabolic syndrome
    David Karásek · 2026 · Vnitřní lékařství
19. Emerging nanostructured platforms for improved oral delivery of antidiabetic agents: overcoming physiological barriers and enhancing therapeutic efficacy
    Shweta Yadav, Prashant Singh, Madhusudan N. Purohit · 2026 · DARU Journal of Pharmaceutical Sciences
20. Machine learning–driven pharmacovigilance of antidiabetic drugs: comparative reporting patterns and classification of serious adverse events
    Soo Hyeon Lee, Seojun Lee, Sangyoon Chris Lee, Yeo Jin Choi · 2026 · European Journal of Clinical Pharmacology
21. Continuous glucose monitoring in insulin-treated diabetes beyond glycemic control and towards precision metabolic care
    Charlotte Delrue, Marijn M. Speeckaert · 2026 · Metabolism and Target Organ Damage
22. Natural Products in Diabetes Mellitus: A Narrative Review of Mechanistic Insights into Metabolic Regulation and Therapeutic Potential
    Hemalata Deshmukh, Ganesh J. Kshirsagar, Lauren Gollahon · 2026 · Nutrients
23. Insulin Intensification and Simplification Strategies in Patients with Type 2 Diabetes and Overweight or Obesity: A Scoping Review
    Chew Huey Chua, Wei Lim Chong, Hasniza Zaman Huri · 2026 · International Journal of Molecular Sciences
24. Pharmacy students’ knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study
    Alaa A. Khojah, Malaz J. Gazzaz, Mohammed M. Aldurdunji, Ahmad SafirAldeen, Ibrahim R. Al-Qurashi, Mohammad A. Alhazmi, Ashraf N. Abdalla, Roaya S. Alqurashi, Saad M. Wali · 2026 · Libyan Journal of Medicine
25. Poloxamer 188 Promotes Severe Aggregation of Insulin under Shaking Conditions
    Ding Zhao-lin, Han Gao, Zi-Ting Xu · 2026 · Molecular Pharmaceutics
26. Transcriptional and phenotypic alterations of regulatory and effector T cells in type 1 diabetes mellitus
    Yutong Li, Xinhui Zhao, Mingxin Xie, Eyad Elkord · 2026 · Molecular Biomedicine
27. CONSTRUÇÃO E VALIDAÇÃO DE CARTILHA EDUCATIVA SOBRE INSULINOTERAPIA PARA ADULTOS E IDOSOS NO AMBIENTE DOMICILIAR
    Clara Jessica Silva Ferreira, Aline Carrilho Menezes, Nelson Miguel Galindo Neto, Priscila Peruzzo Apolinário, Silmara Nunes Andrade, Rayssa Nogueira Rodrigues, Flávia de Oliveira, Danilo Donizetti Trevisan · 2026 · Texto & Contexto - Enfermagem
28. DEVELOPMENT AND VALIDATION OF AN EDUCATIONAL BOOKLET ON INSULIN THERAPY FOR ADULTS AND OLDER ADULTS IN THE HOME SETTING
    Clara Jessica Silva Ferreira, Aline Carrilho Menezes, Nelson Miguel Galindo Neto, Priscila Peruzzo Apolinário, Silmara Nunes Andrade, Rayssa Nogueira Rodrigues, Flávia de Oliveira, Danilo Donizetti Trevisan · 2026 · Texto & Contexto - Enfermagem